Ken Minneman - Publications

Affiliations: 
Emory University, Atlanta, GA 

97 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2007 Bush CF, Jones SV, Lyle AN, Minneman KP, Ressler KJ, Hall RA. Specificity of olfactory receptor interactions with other G protein-coupled receptors. The Journal of Biological Chemistry. 282: 19042-51. PMID 17472961 DOI: 10.1074/Jbc.M610781200  0.395
2006 Chen Z, Hague C, Hall RA, Minneman KP. Syntrophins regulate alpha1D-adrenergic receptors through a PDZ domain-mediated interaction. The Journal of Biological Chemistry. 281: 12414-20. PMID 16533813 DOI: 10.1074/Jbc.M508651200  0.556
2006 Hague C, Lee SE, Chen Z, Prinster SC, Hall RA, Minneman KP. Heterodimers of alpha1B- and alpha1D-adrenergic receptors form a single functional entity. Molecular Pharmacology. 69: 45-55. PMID 16195468 DOI: 10.1124/Mol.105.014985  0.455
2005 Chen ZJ, Minneman KP. Recent progress in alpha1-adrenergic receptor research. Acta Pharmacologica Sinica. 26: 1281-7. PMID 16225747 DOI: 10.1111/J.1745-7254.2005.00224.X  0.531
2005 Hague C, Bernstein LS, Ramineni S, Chen Z, Minneman KP, Hepler JR. Selective inhibition of alpha1A-adrenergic receptor signaling by RGS2 association with the receptor third intracellular loop. The Journal of Biological Chemistry. 280: 27289-95. PMID 15917235 DOI: 10.1074/Jbc.M502365200  0.518
2005 Lima V, Mueller A, Kamikihara SY, Raymundi V, Alewood D, Lewis RJ, Chen Z, Minneman KP, Pupo AS. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta. European Journal of Pharmacology. 508: 183-92. PMID 15680270 DOI: 10.1016/J.Ejphar.2004.12.011  0.539
2005 Uberti MA, Hague C, Oller H, Minneman KP, Hall RA. Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors. The Journal of Pharmacology and Experimental Therapeutics. 313: 16-23. PMID 15615865 DOI: 10.1124/Jpet.104.079541  0.516
2004 Hague C, Hall RA, Minneman KP. Olfactory receptor localization and function: an emerging role for GPCR heterodimerization. Molecular Interventions. 4: 321-2. PMID 15616160 DOI: 10.1124/Mi.4.6.4  0.346
2004 Hague C, Uberti MA, Chen Z, Bush CF, Jones SV, Ressler KJ, Hall RA, Minneman KP. Olfactory receptor surface expression is driven by association with the beta2-adrenergic receptor. Proceedings of the National Academy of Sciences of the United States of America. 101: 13672-6. PMID 15347813 DOI: 10.1073/Pnas.0403854101  0.614
2004 Chen Z, Rogge G, Hague C, Alewood D, Colless B, Lewis RJ, Minneman KP. Subtype-selective noncompetitive or competitive inhibition of human alpha1-adrenergic receptors by rho-TIA. The Journal of Biological Chemistry. 279: 35326-33. PMID 15194691 DOI: 10.1074/Jbc.M403703200  0.461
2004 Hague C, Uberti MA, Chen Z, Hall RA, Minneman KP. Cell surface expression of alpha1D-adrenergic receptors is controlled by heterodimerization with alpha1B-adrenergic receptors. The Journal of Biological Chemistry. 279: 15541-9. PMID 14736874 DOI: 10.1074/Jbc.M314014200  0.457
2004 Hague C, Chen Z, Pupo AS, Schulte NA, Toews ML, Minneman KP. The N terminus of the human alpha1D-adrenergic receptor prevents cell surface expression. The Journal of Pharmacology and Experimental Therapeutics. 309: 388-97. PMID 14718583 DOI: 10.1124/Jpet.103.060509  0.446
2003 Uberti MA, Hall RA, Minneman KP. Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmacological properties. Molecular Pharmacology. 64: 1379-90. PMID 14645668 DOI: 10.1124/mol.64.6.1379  0.342
2003 Hague C, Chen Z, Uberti M, Minneman KP. Alpha(1)-adrenergic receptor subtypes: non-identical triplets with different dancing partners? Life Sciences. 74: 411-8. PMID 14609720 DOI: 10.1016/J.Lfs.2003.07.008  0.517
2003 Lee D, Robeva A, Chen Z, Minneman KP. Mutational uncoupling of alpha1A-adrenergic receptors from G proteins also uncouples mitogenic and transcriptional responses in PC12 cells. The Journal of Pharmacology and Experimental Therapeutics. 306: 471-7. PMID 12724349 DOI: 10.1124/Jpet.103.050500  0.498
2002 Pupo AS, Minneman KP. Interaction of neuronal nitric oxide synthase with alpha1-adrenergic receptor subtypes in transfected HEK-293 cells. Bmc Pharmacology. 2: 17. PMID 12184796 DOI: 10.1186/1471-2210-2-17  0.303
2002 Vicentic A, Robeva A, Rogge G, Uberti M, Minneman KP. Biochemistry and pharmacology of epitope-tagged alpha(1)-adrenergic receptor subtypes. The Journal of Pharmacology and Experimental Therapeutics. 302: 58-65. PMID 12065700 DOI: 10.1124/Jpet.302.1.58  0.317
2001 Pupo AS, Minneman KP. Adrenergic pharmacology: focus on the central nervous system. Cns Spectrums. 6: 656-62. PMID 15520613  0.344
1999 Guerrero SW, Minneman KP. Coupling efficiencies of beta 1- and beta 2-adrenergic receptors expressed alone or together in transfected GH3 pituitary cells. The Journal of Pharmacology and Experimental Therapeutics. 290: 980-8. PMID 10454468  0.532
1998 Williams NG, Zhong H, Minneman KP. Differential coupling of alpha1-, alpha2-, and beta-adrenergic receptors to mitogen-activated protein kinase pathways and differentiation in transfected PC12 cells. The Journal of Biological Chemistry. 273: 24624-32. PMID 9733758 DOI: 10.1074/jbc.273.38.24624  0.386
1996 Zhong H, Guerrero SW, Esbenshade TA, Minneman KP. Inducible expression of beta 1- and beta 2-adrenergic receptors in rat C6 glioma cells: functional interactions between closely related subtypes. Molecular Pharmacology. 50: 175-84. PMID 8700111  0.53
1995 Guerrero SW, Zhong H, Minneman KP. Selective desensitization of beta 1- and beta 2-andrenergic receptors in C6 glioma cells. Effects on catecholamine responsiveness. Receptor. 5: 185-95. PMID 8840397  0.496
1995 Zhong H, Minneman KP. Coexisting beta-1 and beta-2-adrenergic receptors with differential receptor reserves in rat C6 glioma cells. The Journal of Pharmacology and Experimental Therapeutics. 272: 1088-94. PMID 7891320  0.532
1995 Esbenshade TA, Wang X, Williams NG, Minneman KP. Inducible expression of alpha 1B-adrenoceptors in DDT1 MF-2 cells: comparison of receptor density and response. European Journal of Pharmacology. 289: 305-10. PMID 7621904 DOI: 10.1016/0922-4106(95)90108-6  0.356
1994 Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR, Trendelenburg U. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacological Reviews. 46: 121-36. PMID 7938162  0.48
1994 Esbenshade TA, Minneman KP. Adrenergic Receptor Subtypes: Pharmacological Approaches Neuroprotocols. 4: 2-13. DOI: 10.1006/ncmn.1994.1002  0.368
1993 Minneman KP, Esbenshade TA, Zhong H. Interactions between co-existing beta-adrenoceptor subtypes in continuous cell lines. Biochemical Society Transactions. 21: 1109-14. PMID 8131909  0.359
1993 Zhong H, Minneman KP. Close reciprocal regulation of beta 1- and beta 2-adrenergic receptors by dexamethasone in C6 glioma cells: effects on catecholamine responsiveness. Molecular Pharmacology. 44: 1085-93. PMID 7903414  0.504
1992 Atkinson BN, Minneman KP. Occupancy-response relationships for beta- and alpha 2-adrenergic receptors exerting opposing effects on cAMP production. Receptor. 2: 195-206. PMID 1361869  0.489
1992 Esbenshade TA, Han C, Theroux TL, Granneman JG, Minneman KP. Coexisting beta 1- and atypical beta-adrenergic receptors cause redundant increases in cyclic AMP in human neuroblastoma cells. Molecular Pharmacology. 42: 753-9. PMID 1359396  0.537
1992 Atkinson BN, Minneman KP. Preferential desensitization of beta- versus alpha 2-adrenergic receptors accelerates loss of response to norepinephrine in primary glial cultures. Molecular Pharmacology. 41: 688-94. PMID 1349153  0.454
1991 Holtzman SG, Mante S, Minneman KP. Role of adenosine receptors in caffeine tolerance. The Journal of Pharmacology and Experimental Therapeutics. 256: 62-8. PMID 1846425  0.368
1991 Minneman KP, Atkinson B. Interaction of subtype-selective antagonists with alpha 1-adrenergic receptor-mediated second messenger responses in rat brain. Molecular Pharmacology. 40: 523-30. PMID 1681416  0.312
1991 Atkinson BN, Minneman KP. Multiple adrenergic receptor subtypes controlling cyclic AMP formation: comparison of brain slices and primary neuronal and glial cultures. Journal of Neurochemistry. 56: 587-95. PMID 1671087  0.452
1989 Bazil CW, Minneman KP. Clinical concentrations of volatile anesthetics reduce depolarization-evoked release of [3H]norepinephrine, but not [3H]acetylcholine, from rat cerebral cortex. Journal of Neurochemistry. 53: 962-5. PMID 2760627  0.505
1989 Bazil CW, Minneman KP. Anaesthetic concentrations of enflurane and methoxyflurane in rat brain in-vivo and in-vitro. The Journal of Pharmacy and Pharmacology. 41: 835-9. PMID 2576445  0.502
1989 Bazil CW, Minneman KP. Effects of clinically effective concentrations of halothane on adrenergic and cholinergic synapses in rat brain in vitro. The Journal of Pharmacology and Experimental Therapeutics. 248: 143-8. PMID 2536426  0.617
1988 Minneman KP, Mumford GK, Abel PW. High efficiency coupling of alpha-1 adrenergic receptors to inositol phospholipid metabolism revealed by denervation of rat vas deferens. The Journal of Pharmacology and Experimental Therapeutics. 244: 226-30. PMID 2826769  0.333
1988 Minneman KP. β-Adrenergic receptor subtypes Isi Atlas of Science: Pharmacology. 2: 334-338.  0.311
1987 Bazil CW, Raux ME, Yudell S, Minneman KP. Equilibration of halothane with brain tissue in vitro: comparison to brain concentrations during anesthesia. Journal of Neurochemistry. 49: 952-8. PMID 3612133  0.516
1987 Nasseri A, Minneman KP. Relationship between alpha 2-adrenergic receptor binding sites and the functional receptors inhibiting norepinephrine release in rat cerebral cortex. Molecular Pharmacology. 32: 655-62. PMID 2891027  0.344
1987 Han C, Abel PW, Minneman KP. Heterogeneity of alpha 1-adrenergic receptors revealed by chlorethylclonidine. Molecular Pharmacology. 32: 505-10. PMID 2890094  0.358
1987 Johnson RD, Iuvone PM, Minneman KP. Regulation of alpha-1 adrenergic receptor density and functional responsiveness in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 242: 842-9. PMID 2821227  0.412
1987 Johnson RD, Minneman KP. Differentiation of alpha 1-adrenergic receptors linked to phosphatidylinositol turnover and cyclic AMP accumulation in rat brain. Molecular Pharmacology. 31: 239-46. PMID 2436033  0.323
1986 Bazil CW, Minneman KP. An investigation of the low intrinsic activity of adenosine and its analogs at low affinity (A2) adenosine receptors in rat cerebral cortex. Journal of Neurochemistry. 47: 547-53. PMID 3016175  0.598
1986 May JM, Abel PW, Minneman KP. Regulation of beta-adrenoceptor density and function in rat vas deferens. European Journal of Pharmacology. 122: 221-9. PMID 3011443 DOI: 10.1016/0014-2999(86)90106-8  0.403
1986 Abel PW, Minneman KP. Alpha-1 adrenergic receptor binding and contraction of rat caudal artery. The Journal of Pharmacology and Experimental Therapeutics. 239: 678-86. PMID 2879031  0.312
1986 Johnson RD, Minneman KP. Characterization of alpha 1-adrenoceptors which increase cyclic AMP accumulation in rat cerebral cortex. European Journal of Pharmacology. 129: 293-305. PMID 2877887 DOI: 10.1016/0014-2999(86)90439-5  0.368
1986 Minneman KP, Mowry CB. Interactions of putatively irreversible antagonists with beta 1- and beta 2-adrenergic receptors. Biochemical Pharmacology. 35: 857-64. PMID 2869757 DOI: 10.1016/0006-2952(86)90255-8  0.487
1985 Fox AW, Juberg EN, May JM, Johnson RD, Abel PW, Minneman KP. Thyroid status and adrenergic receptor subtypes in the rat: comparison of receptor density and responsiveness. The Journal of Pharmacology and Experimental Therapeutics. 235: 715-23. PMID 3001274  0.51
1985 Sutin J, Minneman KP. Adrenergic beta receptors are not uniformly distributed in the cerebellar cortex. The Journal of Comparative Neurology. 236: 547-54. PMID 2997307 DOI: 10.1002/Cne.902360410  0.567
1985 Abel PW, Fox AW, Minneman KP. Effects of isoxuprine and nylidrin on adrenoreceptors in rat vas deferens. Journal of Autonomic Pharmacology. 5: 213-9. PMID 2997229  0.37
1985 Johnson RD, Minneman KP. Alpha 1-adrenergic receptors and stimulation of [3H]inositol metabolism in rat brain: regional distribution and parallel inactivation. Brain Research. 341: 7-15. PMID 2994816 DOI: 10.1016/0006-8993(85)91466-0  0.329
1985 Abel PW, Johnson RD, Martin TJ, Minneman KP. Sympathetic denervation does not alter the density or properties of alpha-1 adrenergic receptors in rat vas deferens. The Journal of Pharmacology and Experimental Therapeutics. 233: 570-7. PMID 2989488  0.345
1985 Sutin J, Minneman KP. alpha 1- and beta-adrenergic receptors are co-regulated during both noradrenergic denervation and hyperinnervation. Neuroscience. 14: 973-80. PMID 2987756 DOI: 10.1016/0306-4522(85)90269-6  0.523
1985 May JM, Abel PW, Minneman KP. Binding of agonists and antagonists to beta-adrenoceptors in rat vas deferens: relationship to functional response. Naunyn-Schmiedeberg's Archives of Pharmacology. 331: 324-33. PMID 2869414 DOI: 10.1007/BF00500814  0.427
1985 Juberg EN, Minneman KP, Abel PW. Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart. Naunyn-Schmiedeberg's Archives of Pharmacology. 330: 193-202. PMID 2865685 DOI: 10.1007/BF00572434  0.47
1985 May JM, Abel PW, Minneman KP. Regulation of β2-adrenergic receptors in rat vas deferens Federation Proceedings. 44: No. 8309.  0.335
1984 Minneman KP. Receptor thermodynamics. Monographs in Neural Sciences. 10: 20-6. PMID 6321970  0.375
1984 Minneman KP, Abel PW. Relationship between alpha 1-adrenoceptor density and functional response of rat vas deferens. Studies with phenoxybenzamine. Naunyn-Schmiedeberg's Archives of Pharmacology. 327: 238-46. PMID 6149471 DOI: 10.1007/BF00502456  0.327
1984 Minneman KP, Johnson RD. Characterization of alpha-1 adrenergic receptors linked to [3H]inositol metabolism in rat cerebral cortex. The Journal of Pharmacology and Experimental Therapeutics. 230: 317-23. PMID 6146710  0.335
1984 Minneman KP, Abel PW. "Spare" alpha 1-adrenergic receptors and the potency of agonists in rat vas deferens. Molecular Pharmacology. 25: 56-63. PMID 6143249  0.408
1984 Minneman KP, Holtzman SG. Morphine dependence and withdrawal without alterations in cerebral beta-adrenergic receptor density. Biochemical Pharmacology. 33: 2331-3. PMID 6087822 DOI: 10.1016/0006-2952(84)90676-2  0.491
1984 May JM, Abel PW, Minneman KP. Characterization of a homogenous population of β2-adrenergic receptors in rat vas deferens: Radioligand binding and functional response Federation Proceedings. 43: no. 2684.  0.306
1984 Abel PW, Johnson RD, Martin TJ, Minneman KP. Effect of surgical denervation on α1 adrenergic receptors in rat vas deferens Federation Proceedings. 43: no. 15.  0.317
1983 Minneman KP. Phenoxybenzamine is more potent in inactivating alpha 1- than alpha 2-adrenergic receptor binding sites. European Journal of Pharmacology. 94: 171-4. PMID 6317400 DOI: 10.1016/0014-2999(83)90458-2  0.332
1983 Minneman KP, Puckett AM, Jensen AD, Rinard GA. Regional variation in beta adrenergic receptors in dog trachea: correlation of receptor density and in vitro relaxation. The Journal of Pharmacology and Experimental Therapeutics. 226: 140-6. PMID 6306221  0.524
1983 Minneman KP, Wolfe BB, Pittman RN, Molinoff PB. beta-Adrenergic receptor subtypes in rat brain. Advances in Biochemical Psychopharmacology. 36: 73-81. PMID 6305157  0.792
1983 Minneman KP. Peripheral catecholamine administration does not alter cerebral beta-adrenergic receptor density. Brain Research. 264: 328-31. PMID 6303503 DOI: 10.1016/0006-8993(83)90835-1  0.541
1983 Minneman KP, Fox AW, Abel PW. Occupancy of alpha 1-adrenergic receptors and contraction of rat vas deferens. Molecular Pharmacology. 23: 359-68. PMID 6300645  0.368
1983 Minneman KP. Binding properties of alpha-1 adrenergic receptors in rat cerebral cortex: similarity to smooth muscle. The Journal of Pharmacology and Experimental Therapeutics. 227: 605-12. PMID 6140305  0.344
1982 Minneman KP, Wolfe BB, Molinoff PB. Selective changes in the density of beta 1-adrenergic receptors in rat striatum following chronic drug treatment and adrenalectomy. Brain Research. 252: 309-14. PMID 6295545 DOI: 10.1016/0006-8993(82)90398-5  0.78
1982 Wolfe BB, Minneman KP, Molinoff PB. Selective increases in the density of cerebellar beta-1-adrenergic receptors. Brain Research. 234: 474-9. PMID 6277437 DOI: 10.1016/0006-8993(82)90890-3  0.784
1981 Minneman KP, Pittman RN, Yeh HH, Woodward DJ, Wolfe BB, Molinoff PB. Selective survival of beta 1-adenergic receptors in rat cerebellum following neonatal x-irradiation. Brain Research. 209: 25-34. PMID 6260307 DOI: 10.1016/0006-8993(81)91169-0  0.8
1981 Molinoff PB, Weiland GA, Heidenreich KA, Pittman RN, Minneman KP. Interactions of agonists and antagonists with beta-adrenergic receptors. Advances in Cyclic Nucleotide Research. 14: 51-67. PMID 6116391  0.736
1981 Minneman KP, Pittman RN, Molinoff PB. Beta-adrenergic receptor subtypes: properties, distribution, and regulation. Annual Review of Neuroscience. 4: 419-61. PMID 6111980 DOI: 10.1146/annurev.ne.04.030181.002223  0.75
1980 Pittman RN, Minneman KP, Molinoff PB. Alterations in beta 1- and beta 2-adrenergic receptor density in the cerebellum of aging rats. Journal of Neurochemistry. 35: 273-5. PMID 6256478 DOI: 10.1111/j.1471-4159.1980.tb12517.x  0.772
1980 Minneman KP, Molinoff PB. Classification and quantitation of beta-adrenergic receptor subtypes. Biochemical Pharmacology. 29: 1317-23. PMID 6249311 DOI: 10.1016/0006-2952(80)90424-4  0.716
1980 Minneman KP, Weiland GA, Molinoff PB. A comparison of the beta-adrenergic receptor of the turkey erythrocyte with mammalian beta1 and beta2 receptors. Molecular Pharmacology. 17: 1-7. PMID 6247636  0.715
1980 Pittman RN, Minneman KP, Molinoff PB. Ontogeny of beta 1- and beta 2-adrenergic receptors in rat cerebellum and cerebral cortex. Brain Research. 188: 357-68. PMID 6245756 DOI: 10.1016/0006-8993(80)90037-2  0.778
1980 Hedberg A, Minneman KP, Molinoff PB. Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea-pig heart. The Journal of Pharmacology and Experimental Therapeutics. 212: 503-8. PMID 6244386  0.716
1980 Weiland GA, Minneman KP, Molinoff PB. Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors. Molecular Pharmacology. 18: 341-7. PMID 6110167  0.714
1979 Sinensky M, Minneman KP, Molinoff PB. Increased membrane acyl chain ordering activates adenylate cyclase. The Journal of Biological Chemistry. 254: 9135-41. PMID 479183  0.419
1979 Hedberg A, Minneman KP, Molinoff PB. Regional distribution of beta 1- and beta 2-adrenoceptors in the right atrium and left ventricle of the cat and guinea pig heart [proceedings]. British Journal of Pharmacology. 66: 505P. PMID 230883  0.611
1979 Minneman KP, Hedberg A, Molinoff PB. Comparison of beta adrenergic receptor subtypes in mammalian tissues. The Journal of Pharmacology and Experimental Therapeutics. 211: 502-8. PMID 229209  0.703
1979 Zahniser NR, Minneman KP, Molinoff PB. Persistence of beta-adrenergic receptors in rat striatum following kainic acid administration. Brain Research. 178: 589-95. PMID 228797 DOI: 10.1016/0006-8993(79)90720-0  0.769
1979 Hegstrand LR, Minneman KP, Molinoff PB. Multiple effects of guanosine triphosphate on beta adrenergic receptors and adenylate cyclase activity in rat heart, lung and brain. The Journal of Pharmacology and Experimental Therapeutics. 210: 215-21. PMID 222893  0.666
1979 Minneman KP, Hegstrand LR, Molinoff PB. Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes. Molecular Pharmacology. 16: 34-46. PMID 39246  0.721
1979 Minneman KP, Hegstrand LR, Molinoff PB. The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro. Molecular Pharmacology. 16: 21-33. PMID 39243  0.692
1979 Weiland GA, Minneman KP, Molinoff PB. Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor. Nature. 281: 114-7. PMID 38405 DOI: 10.1038/281114a0  0.678
1979 Minneman KP, Dibner MD, Wolfe BB, Molinoff PB. beta1- and beta2-Adrenergic receptors in rat cerebral cortex are independently regulated. Science (New York, N.Y.). 204: 866-8. PMID 35829 DOI: 10.1126/Science.35829  0.778
1979 Minneman KP, Wolfe BB, Dibner MD, Molinoff PB. β-1 and β-2-adrenergic receptors in rat cerebral cortex have different endogenous inputs Federation Proceedings. 38: No. 1922.  0.531
1979 Hedberg A, Minneman KP, Molinoff PB. Differential distribution of β1- and β2-adrenoceptors in cat and guinea pig heart Acta Physiologica Scandinavica. 107: No. 51.  0.421
1978 Minneman KP, Quik M, Emson PC. Receptor-linked cyclic AMP systems in rat neostriatum: differential localization revealed by kainic acid injection. Brain Research. 151: 507-21. PMID 27287 DOI: 10.1016/0006-8993(78)91083-1  0.366
1976 Minneman KP, Wurtman RJ. The pharmacology of the pineal gland. Annual Review of Pharmacology and Toxicology. 16: 33-51. PMID 180879 DOI: 10.1146/annurev.pa.16.040176.000341  0.343
1976 Minneman KP, Iversen LL. Cholera toxin induces pineal enzymes in culture. Science (New York, N.Y.). 192: 803-5. PMID 178053  0.307
1974 Minneman KP, Lynch H, Wurtman RJ. Relationship between environmental light intensity and retina-mediated suppression of rat pineal serotonin-N-acetyl-transferase. Life Sciences. 15: 1791-6. PMID 4620990 DOI: 10.1016/0024-3205(74)90180-5  0.335
Show low-probability matches.